CA2391274A1 — Method for detecting pathogenic microorganism and antimicrobial agent, method for evaluating effect of antimicrobial agent, and antimicrobial agent
Assigned to Kaken Pharmaceutical Co Ltd · Expires 2001-02-01 · 25y expired
What this patent protects
A novel method for evaluating the drug effect of an antimicrobial agent whic h comprises eliminating the antimicrobial agent remaining in a biological sample, etc. to thereby accurately evaluate the drug effect of the antimicrobial agent without being affected by the remaining an…
USPTO Abstract
A novel method for evaluating the drug effect of an antimicrobial agent whic h comprises eliminating the antimicrobial agent remaining in a biological sample, etc. to thereby accurately evaluate the drug effect of the antimicrobial agent without being affected by the remaining antimicrobial agent. Remedies for nail mycosis which can be obtained by the drug effect evaluation method as described above.
Drugs covered by this patent
- Jublia (EFINACONAZOLE) · Bausch Health
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.